| P50 | author | José-Antonio Girón-González | Q59697554 |
| P2093 | author name string | Francisca M Guerrero-Sánchez | |
| | Andrés Martín-Aspas | |
| | Francisco García-Colchero | |
| | Sebastián Rodríguez-Roca | |
| P2860 | cites work | Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance. | Q51664584 |
| | Actividad de 18 agentes antimicrobianos frente a aislados clínicos de Acinetobacter baumannii: segundo estudio nacional multicéntrico (proyecto GEIH-REIPI-Ab 2010) | Q57596604 |
| | Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility | Q73037887 |
| | Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections | Q78524086 |
| | Ventilator-Associated Tracheobronchitis in a Mixed Surgical and Medical ICU Population | Q84774257 |
| | Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis | Q27005655 |
| | An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii | Q28257612 |
| | A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 |
| | APACHE II: a severity of disease classification system | Q29547729 |
| | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance | Q29617469 |
| | 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference | Q29618757 |
| | Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients? | Q31113551 |
| | Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. | Q33970252 |
| | Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit | Q34003193 |
| | A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study. | Q34611874 |
| | Acinetobacter baumannii: emergence of a successful pathogen | Q34795807 |
| | Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. | Q35005719 |
| | Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance | Q35551122 |
| | Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal | Q36150941 |
| | The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 |
| | The importance of colonization pressure in multiresistant Acinetobacter baumannii acquisition in a Greek intensive care unit | Q36633704 |
| | Ventilator-associated tracheobronchitis: the impact of targeted antibiotic therapy on patient outcomes | Q37277458 |
| | Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach. | Q37439554 |
| | Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options | Q37960325 |
| | Incidence and outcomes of ventilator-associated tracheobronchitis and pneumonia | Q40252102 |
| | Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study | Q40426438 |
| | Nosocomial pneumonia in non-invasive ventilation patients: incidence, characteristics, and outcomes | Q41080573 |
| | Description of the OXA-23 β-lactamase gene located within Tn2007 in a clinical isolate of Acinetobacter baumannii from Spain | Q41668012 |
| | Attributable mortality of Acinetobacter baumannii: no longer a controversial issue | Q41815193 |
| | Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals | Q42167294 |
| | Carbapenem and multidrug-resistant Acinetobacter baumannii colonisation/infection: epidemiology and factors associated with infection | Q43028928 |
| | Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London | Q43243274 |
| | CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting | Q43758287 |
| | Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection | Q43843241 |
| | Eighteen years of experience with Acinetobacter baumannii in a tertiary care hospital | Q44300585 |
| | Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences | Q45048702 |
| | Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort. | Q46198938 |
| | Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex | Q46477702 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Acinetobacter baumannii | Q3241189 |
| P304 | page(s) | 861-872 | |
| P577 | publication date | 2018-06-06 | |
| P1433 | published in | Infection and Drug Resistance | Q15716352 |
| P1476 | title | Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality | |
| P478 | volume | 11 | |